| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 6248 | 2008 |
| DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease Z Hong, M Shi, KA Chung, JF Quinn, ER Peskind, D Galasko, J Jankovic, ... Brain 133 (3), 713-726, 2010 | 725 | 2010 |
| A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study Parkinson Study Group Archives of neurology 59 (12), 1937-1943, 2002 | 711 | 2002 |
| Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 490 | 2015 |
| Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression M Shi, J Bradner, AM Hancock, KA Chung, JF Quinn, ER Peskind, ... Annals of neurology 69 (3), 570-580, 2011 | 474 | 2011 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 418 | 2012 |
| Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis P Greene, U Kang, S Fahn, M Brin, C Moskowitz, E Flaster Neurology 40 (8), 1213-1213, 1990 | 390 | 1990 |
| Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of … M Levivier, S Przedborski, C Bencsics, UJ Kang Journal of Neuroscience 15 (12), 7810-7820, 1995 | 358 | 1995 |
| Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons S Chung, KC Sonntag, T Andersson, LM Bjorklund, JJ Park, DW Kim, ... European Journal of Neuroscience 16 (10), 1829-1838, 2002 | 321 | 2002 |
| Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice L Chen, B Cagniard, T Mathews, S Jones, HC Koh, Y Ding, PM Carvey, ... Journal of Biological Chemistry 280 (22), 21418-21426, 2005 | 306 | 2005 |
| Behavioral models of Parkinson's disease in rodents: a new look at an old problem GE Meredith, UJ Kang Movement disorders 21 (10), 1595-1606, 2006 | 296 | 2006 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 292 | 2014 |
| Characterization of PINK1 processing, stability, and subcellular localization W Lin, UJ Kang Journal of neurochemistry 106 (1), 464-474, 2008 | 287 | 2008 |
| Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice DY Hwang, P Ardayfio, UJ Kang, EV Semina, KS Kim Molecular Brain Research 114 (2), 123-131, 2003 | 286 | 2003 |
| Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions JW Chang, SR Wachtel, D Young, UJ Kang Neuroscience 88 (2), 617-628, 1999 | 285 | 1999 |
| Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice L Chen, Y Ding, B Cagniard, AD Van Laar, A Mortimer, W Chi, ... Journal of Neuroscience 28 (2), 425-433, 2008 | 270 | 2008 |
| A controlled trial of rotigotine monotherapy in early Parkinson's disease Parkinson Study Group Archives of neurology 60 (12), 1721-1728, 2003 | 266 | 2003 |
| Impact of the COVID‐19 pandemic on Parkinson's disease and movement disorders SM Papa, P Brundin, VSC Fung, UJ Kang, DJ Burn, C Colosimo, ... Movement disorders clinical practice 7 (4), 357, 2020 | 263 | 2020 |
| Striatal cholinergic interneuron regulation and circuit effects SAO Lim, UJ Kang, DS McGehee Frontiers in synaptic neuroscience 6, 22, 2014 | 253 | 2014 |
| Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease D Sulzer, C Cassidy, G Horga, UJ Kang, S Fahn, L Casella, G Pezzoli, ... NPJ Parkinson's disease 4 (1), 11, 2018 | 223 | 2018 |
